Hitiq logo

Hitiq(ASX) HIQ

Market CapA$5.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-97%
5 Year-95%
1 Year-77%
1 Month-17%
A$0.01
+0.00%
+0.00Today
Hitiq last closing stock price
MetricPriceDate
Last closeAUD 0.012026-10-08
Hitiq stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+25%AUD 0.002026-09-30
1 month-16.67%AUD 0.012026-09-08
3 month-37.5%AUD 0.012026-07-10
Year to date-76.19%AUD 0.022025-12-31
1 year-77.27%AUD 0.022025-10-08
3 year-72.22%AUD 0.022023-10-09
5 year-95.26%AUD 0.112021-10-08
Since inception-96.91%AUD 0.162021-06-16

Hitiq Financials at a Glance

Market Cap

A$5.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$2.38M

Net Income (TTM)

-A$13.31M

EPS (TTM)

-A$0.01

P/E Ratio

-0.46

Dividend

A$0.00

Beta (Volatility)

-0.05 (Low)

Price

A$0.01

Volume

250,000

Open

A$0.01

Previous Close

A$0.01

Daily Range

A$0.01 - A$0.01

52-Week Range

A$0.00 - A$0.04

Estimated Earnings Date

Nov 28, 2024

HIQ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hitiq

HITIQ Limited is an Australian company dedicated to developing advanced technology for concussion management. The company’s innovative software and tools provide critical data and insights to enhance athlete care and safety.

Products and Services
  • Nexus software platform for comprehensive head impact data analysis
  • CoVR, a virtual reality system for cognitive function assessment
  • CSX, a sideline tool for efficient concussion evaluation
Growth Outlook
  • Recent quarterly revenue increased to AUD 115,660, showing potential for growth
  • Gross profit margin improved to 81.1% in the latest quarter
  • Focus on expanding market presence in concussion management technology
Financial Highlights
  • Trailing twelve months revenue of AUD 1,115,000 indicates steady demand
  • Net income for the latest quarter was AUD -3,202,604, reflecting ongoing investment in R&D
  • Cash and cash equivalents at AUD 173,638, supporting operational needs
HITIQ Limited operates in the healthcare information services sector, focusing on athlete safety through technology. The Nexus platform offers a unique approach to concussion management, providing real-time data that can significantly impact decision-making in sports. The CoVR system enhances cognitive assessments, while the CSX tool simplifies concussion evaluations, making it easier for medical professionals to coordinate care. The company has shown promising growth potential, with recent revenue trends indicating an upward trajectory. The improvement in gross profit margin suggests effective cost management and operational efficiency. Despite challenges reflected in net income figures, the commitment to research and development positions HITIQ for future advancements and market expansion. With a focus on innovative solutions in a growing industry, HITIQ Limited presents an intriguing opportunity for investors interested in healthcare technology.
AI Generated • Sep 21, 2026

Industry

Health Care Technology

CEO

Michael Dean Vegar

Headquarters

Melbourne, VIC 3205, AU

HIQ Financials

Key Financial Metrics (TTM)

Gross Margin

79.38%

Operating Margin

-1758.95%

Net Income Margin

-1665.46%

Return on Equity

106.16%

Return on Capital

N/A

Return on Assets

-354.62%

Earnings Yield

-2.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$5.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.16B

Volume

250.00K

Avg. Volume

1.54M

Financials (TTM)

Gross Profit

-A$1.89M

Operating Income

-A$12.21M

EBITDA

-A$12.13M

Operating Cash Flow

-A$8.32M

Capital Expenditure

-A$59.59K

Free Cash Flow

-A$8.38M

Cash & ST Invst.

A$173.64K

Total Debt

A$2.27M

Hitiq Performance Analysis

Hitiq annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 774,26026.4%
20242024-06-30AUD 1,123,00045.0%
20252025-06-30AUD 673,250-40.0%
20262026-06-30AUD 366,334-45.6%
Hitiq sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3153.5%
Q42025-06-30-4.5%
Q22025-12-31-74.5%
Q42026-06-30-53.9%
Hitiq annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.02-32.8%
20242024-06-30AUD -0.01-62.9%
20252025-06-30AUD -0.0270.7%
20262026-06-30AUD -0.01-31.2%
Hitiq sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-83.3%
Q42025-06-3018.2%
Q22025-12-3123.6%
Q42026-06-303.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$115.66K

-82.8%

Gross Profit

A$93.82K

-77.9%

Gross Margin

81.11%

N/A

Market Cap

A$5.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$231.78K

N/A

Employees

25

N/A

Net Income

-A$3.20M

-92.6%

EBITDA

-A$3.29M

-164.7%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$173.64K

-70.3%

Total Debt

A$2.27M

-28.9%

Accounts Receivable

A$1.24M

-43.5%

Inventory

A$0.00

N/A

Long Term Debt

A$89.18K

-68.8%

Short Term Debt

A$2.18M

-25.0%

Return on Assets

-3.55%

N/A

Return on Invested Capital

1.04%

N/A

Free Cash Flow

-A$550.74K

+80.8%

Operating Cash Flow

-A$519.72K

+81.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ACR.AXAcrux Limited
A$0.01+10.00%
VBS.AXVectus Biosystems Limited
A$0.11+0.00%
PER.AXPercheron Therapeutics Limited
A$0.00+0.00%
CAN.AXCann Group Limited
A$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$22.08-10.24%
VEEAVeea
$6.33+63.55%
SPCXSpace Exploration Technologies
$163.33+1.72%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$34.60+2.39%

Questions About HIQ

What is the current price of Hitiq?

Hitiq is trading at A$0.01 per share.

What is the 52-week range for Hitiq?

Over the past 52 weeks, Hitiq has traded between A$0.00 and A$0.04.

How much debt does Hitiq have?

As of the most recent reporting period, Hitiq reported total debt of A$2.27M.

How much cash does Hitiq have on hand?

Hitiq reported A$173.64K in cash and cash equivalents in its most recent financial results.

What is Hitiq’s dividend yield?

Hitiq does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.